Synthetic epigenomes for open cross-platform episignature classifiers
Authors:
Preprint
Abstract
DNA methylation (DNAm) signature (episignature) classifiers support diagnosis of rare diseases. Yet episignature testing is confined to a dedicated array platform, and most classifiers are neither openly available nor fully reproducible. Laboratories cannot train their own classifiers as positive controls are scarce and cannot be shared under privacy regulations. Here, we develop and release MethaDory, a framework to train episignature classifiers using synthetic DNAm profiles generated in silico from control data and summary statistics of affected individuals from any platform of interest. We trained 188 classifiers spanning 102 rare disorders and validated 154 across 915 individuals with an episignature-associated diagnosis, 533 healthy controls profiled with DNAm arrays, Oxford Nanopore, and PacBio sequencing, together with 7 international centres. MethaDory achieved an average F1 0.9 on arrays, matching or outperforming existing approaches. We show MethaDory classifier application to long-read genome data, facilitating diagnoses in unsolved cases and in ultra-rapid diagnostic settings.Keywords
This publication has 209 references indexed in Scilit:
- Blepharophimosis with intellectual disability and Helsmoortel‐Van Der Aa Syndrome share episignature and phenotypeAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2024
- The detection of a strong episignature for Chung–Jansen syndrome, partially overlapping with Börjeson–Forssman–Lehmann and White–Kernohan syndromesHuman Genetics, 2024
- Alterations of DNA methylation profile in peripheral blood of children with simple obesityHealth Information Science and Systems, 2024
- Comprehensive evaluation of the implementation of episignatures for diagnosis of neurodevelopmental disorders (NDDs)Human Genetics, 2023
- DNA methylome profiling of blood to identify individuals in a pair of monozygotic twinsGenes & Genomics, 2023
- DNA methylation signatures for chromatinopathies: current challenges and future applicationsHuman Genetics, 2023
- Functional correlation of genome‐wide DNA methylation profiles in genetic neurodevelopmental disordersHuman Mutation, 2022
- Genome‐wide identification of age‐related CpG sites for age estimation from blood DNA of Han Chinese individualsElectrophoresis, 2021
- EpigenCentral: Portal for DNA methylation data analysis and classification in rare diseasesHuman Mutation, 2020
- Critical evaluation of copy number variant calling methods using DNA methylationGenetic Epidemiology, 2019